Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
72.20
+1.74 (2.47%)
At close: Oct 30, 2025, 4:00 PM EDT
72.99
+0.79 (1.09%)
After-hours: Oct 30, 2025, 5:42 PM EDT
Mirum Pharmaceuticals Employees
Mirum Pharmaceuticals had 322 employees as of December 31, 2024. The number of employees increased by 58 or 21.97% compared to the previous year.
Employees
322
Change (1Y)
58
Growth (1Y)
21.97%
Revenue / Employee
$1,332,798
Profits / Employee
-$181,873
Market Cap
3.63B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 322 | 58 | 21.97% |
| Dec 31, 2023 | 264 | 68 | 34.69% |
| Dec 31, 2022 | 196 | 59 | 43.07% |
| Dec 31, 2021 | 137 | 69 | 101.47% |
| Dec 31, 2020 | 68 | 35 | 106.06% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MIRM News
- 2 days ago - Mirum Pharmaceuticals to Announce Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025 - Business Wire
- 20 days ago - Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 7 weeks ago - Mirum Pharmaceuticals, Inc. (MIRM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 7 weeks ago - Mirum Pharmaceuticals Announces Enrollment Completion in the Phase 2b VISTAS Study - Business Wire
- 2 months ago - Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences - Business Wire
- 2 months ago - Mirum Pharmaceuticals: Q2 Results Continue To Show Positive Momentum - Seeking Alpha
- 3 months ago - Mirum Pharmaceuticals, Inc. (MIRM) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Mirum Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update - Business Wire